Physician profile
Thomas J Jacques
NPI 1609006592
$3,542.56
in general payments reported to CMS, 2019-2025
13 companies · $200 in 2025
The $200 reported for 2025 was more than what 81% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,863 · 2020: $535 · 2021: $129 · 2022: $800 · 2024: $15.78 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $786.19 | 2019 | |
| Abbott Laboratories | $773.54 | 2019-2020 | |
| Si-Bone, INC. | $650.70 | 2022 | |
| Nevro Corp. | $393.26 | 2019 | |
| Boston Scientific Corporation | $249.36 | 2019 | |
| Medtronic, INC. | $232.27 | 2021-2022 | |
| Electronic Waveform Lab, INC. | $226.56 | 2022-2025 | |
| Daiichi Sankyo INC. | $78.00 | 2019 | |
| Collegium Pharmaceutical, INC. | $74.07 | 2019 | |
| Pfizer INC. | $25.92 | 2019 | |
| Stimwave Technologies Incorporated | $18.95 | 2021 | |
| Tersera Therapeutics LLC | $17.96 | 2019 | |
| Abbvie INC. | $15.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Jacques listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.